moxifloxacin has been researched along with Eye Diseases in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 2 (50.00) | 2.80 |
Authors | Studies |
---|---|
Gümüş, G; Kara, N; Karatas Durusoy, G; Öcal, MC | 1 |
Jeeva, IK; Masud, S; Siddiqui, MAR | 1 |
Akyürek, N; Deren, YT; Hasanreisoğlu, B; Kalkanci, A; Ozdek, S | 1 |
Bouffioux, C; Caspers, L; Deflorenne, C; Janssens, X; Koch, P; Willermain, F | 1 |
4 other study(ies) available for moxifloxacin and Eye Diseases
Article | Year |
---|---|
Cases of toxic anterior segment syndrome after primary pterygium surgery.
Topics: Anterior Eye Segment; Conjunctiva; Eye Diseases; Fibrin; Formaldehyde; Humans; Hyaluronic Acid; Moxifloxacin; Phacoemulsification; Postoperative Complications; Prednisolone; Pterygium; Syndrome | 2022 |
Efficacy and safety of intravitreal injection of triamcinolone-moxifloxacin after cataract surgery in a low to middle income country - a one-year audit.
Topics: Adult; Aged; Cataract; Cataract Extraction; Developing Countries; Endophthalmitis; Eye Diseases; Female; Glucocorticoids; Humans; Inflammation; Intravitreal Injections; Male; Middle Aged; Moxifloxacin; Postoperative Complications; Retrospective Studies; Triamcinolone | 2023 |
Comparison of antifungal efficacies of moxifloxacin, liposomal amphotericin B, and combination treatment in experimental Candida albicans endophthalmitis in rabbits.
Topics: Amphotericin B; Animals; Antifungal Agents; Aza Compounds; Candida albicans; Candidiasis; Colony Count, Microbial; Disease Models, Animal; Drug Resistance, Fungal; Drug Therapy, Combination; Endophthalmitis; Eye Diseases; Eye Infections, Bacterial; Eye Infections, Fungal; Fluoroquinolones; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Rabbits; Vitreous Body | 2010 |
Uveitis-like syndrome and iris transillumination after the use of oral moxifloxacin.
Topics: Adult; Anti-Infective Agents; Aza Compounds; Eye Diseases; Fluoroquinolones; Humans; Intraocular Pressure; Iris; Laser Coagulation; Male; Moxifloxacin; Pigmentation Disorders; Quinolines; Transillumination; Treatment Outcome; Uveitis, Anterior | 2010 |